Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
There is an entrepreneur who rarely stays out of the media when it comes to the pharmaceutical industry in Brazil: João Adibe. President and CEO of Grupo Cimed, he is practically synonymous with transformation and rapid growth in this sector.
What draws attention to João Adibe is that he does not follow the pattern of traditional corporate executives. He grew up in the business — starting at age 15 helping his father in the Hornoterápica laboratory. His grandfather, João Marques, was a pioneer founding Laboratório Prata in the 1950s. In other words, pharmacy is in the family’s DNA.
Cimed was officially founded in 1977, as a result of a merger between companies in the sector. For 30 years, João Adibe’s father and his sister Karla managed the business. Then João took over as president and began restructuring.
And here’s where it gets interesting. When João Adibe took the reins, he completely changed the positioning. Cimed stopped being just a laboratory and became a popular brand focused on affordable medicines, generics, vitamins, and supplements. An aggressive entry into the generics market, targeting consumers with lower purchasing power, with nationwide reach. The numbers speak for themselves: presence in about 90% of Brazilian pharmacies, over 600 products in the portfolio, 5,000 employees.
In 2018, revenue surpassed R$ 1 billion. Two years later, it was already at R$ 2 billion. The pandemic accelerated everything — demand for vitamins and supplements grew by 35%, solidifying Cimed as one of the four largest in the country.
But João Adibe didn’t stop there. He began associating the company with larger-scale innovation. He announced investments of around R$ 300 million over five years in space research, including on the International Space Station. The goal? Develop new products and position Cimed as a biotech company, not just a traditional pharmaceutical.
Outside of the corporate world, he built a strong presence in sports — sponsorships in football, volleyball with national titles, Stock Car with his own team. On social media, he shares his routine and personal philosophy with the hashtag FlyNow. He was included among Latin America’s 500 most influential people by Bloomberg Línea.
What sets João Adibe apart is this combination: solid family roots, practical execution, aggressive marketing, and long-term vision. He kept Cimed 100% Brazilian and family-controlled while the sector was consolidating under international giants. That’s no trivial feat. It shows that in the business world, operational discipline, brand positioning, and market insight can be just as decisive as pure innovation.